West Announces First Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
West Pharma (WST) Tops Q1 EPS by 5c
April 30, 2015 7:09 AM EDTWest Pharma (NYSE: WST) reported Q1 EPS of $0.45, $0.05 better than the analyst estimate of $0.40. Revenue for the quarter came in at $335.9 million, or $369.4 constant currency, versus the consensus estimate of $346.64 million.
West Pharma sees FY2015 EPS of $1.69-$1.84, versus the consensus of $1.84.
"West had a very good start to 2015 despite the challenge presented by the strengthening U.S. dollar," said Donald E. Morel Jr., PhD, West's Chairman. "The keys to our performance were the particularly strong growth in high-value packaging component sales, which had declined in the 2014 quarter, and managing our... More
